These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31269923)

  • 41. Pneumonia in solid organ transplant recipients: a prospective multicenter study.
    Giannella M; Muñoz P; Alarcón JM; Mularoni A; Grossi P; Bouza E;
    Transpl Infect Dis; 2014 Apr; 16(2):232-41. PubMed ID: 24593292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treating tuberculosis in solid organ transplant recipients.
    Sun HY
    Curr Opin Infect Dis; 2014 Dec; 27(6):501-5. PubMed ID: 25211360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical operational tolerance after solid organ transplantation.
    Di Cocco P; Bonanni L; D'Angelo M; Clemente K; Greco S; Rizza V; Mazzotta C; Scelzo C; Famulari A; Pisani F; Orlando G
    Transplant Proc; 2009 May; 41(4):1278-82. PubMed ID: 19460538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of cytomegalovirus following solid organ transplantation: a literature review.
    Kowalsky S; Arnon R; Posada R
    Pediatr Transplant; 2013 Sep; 17(6):499-509. PubMed ID: 23890075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients.
    Timsit JF; Sonneville R; Kalil AC; Bassetti M; Ferrer R; Jaber S; Lanternier F; Luyt CE; Machado F; Mikulska M; Papazian L; Pène F; Poulakou G; Viscoli C; Wolff M; Zafrani L; Van Delden C
    Intensive Care Med; 2019 May; 45(5):573-591. PubMed ID: 30911807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Future trends in organ transplant recipients--important issues for dermatologists.
    Zecher D; Steiger J
    Curr Probl Dermatol; 2012; 43():71-80. PubMed ID: 22377921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunosuppressant Drugs and Their Effects on Children Undergoing Solid Organ Transplant.
    Spinner JA; Denfield SW
    Pediatr Rev; 2022 Feb; 43(2):71-86. PubMed ID: 35102401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Revisiting transplant immunology through the lens of single-cell technologies.
    Barbetta A; Rocque B; Sarode D; Bartlett JA; Emamaullee J
    Semin Immunopathol; 2023 Jan; 45(1):91-109. PubMed ID: 35980400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Comprehensive Review of Immunization Practices in Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.
    Chong PP; Avery RK
    Clin Ther; 2017 Aug; 39(8):1581-1598. PubMed ID: 28751095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opportunistic infections complicating solid organ transplantation with alemtuzumab induction.
    Helfrich M; Ison MG
    Transpl Infect Dis; 2015 Oct; 17(5):627-36. PubMed ID: 26228653
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Rationale for Age-Adapted Immunosuppression in Organ Transplantation.
    Krenzien F; ElKhal A; Quante M; Rodriguez Cetina Biefer H; Hirofumi U; Gabardi S; Tullius SG
    Transplantation; 2015 Nov; 99(11):2258-68. PubMed ID: 26244716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infections in solid organ transplant HIV-infected patients.
    Miro JM; Agüero F; Duclos-Vallée JC; Mueller NJ; Grossi P; Moreno A;
    Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():119-30. PubMed ID: 25040016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of dyslipidemia in adult solid organ transplant recipients.
    Warden BA; Duell PB
    J Clin Lipidol; 2019; 13(2):231-245. PubMed ID: 30928441
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections.
    Duncan MD; Wilkes DS
    Proc Am Thorac Soc; 2005; 2(5):449-55. PubMed ID: 16322599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hot-topic debate on tolerance: immunosuppression withdrawal.
    Sánchez-Fueyo A
    Liver Transpl; 2011 Nov; 17 Suppl 3():S69-73. PubMed ID: 21850680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pulmonary infections following solid organ transplantation].
    Müller V; Kováts Z; Horváth G
    Orv Hetil; 2012 Jun; 153(23):899-903. PubMed ID: 22668590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection.
    Bhorade SM; Janata K; Vigneswaran WT; Alex CG; Garrity ER
    J Heart Lung Transplant; 2008 Sep; 27(9):990-4. PubMed ID: 18765191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infectious complications of solid organ transplantations.
    Simon DM; Levin S
    Infect Dis Clin North Am; 2001 Jun; 15(2):521-49. PubMed ID: 11447708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Infections in solid organ transplantation in special situations: HIV-infection and immigration.
    Miró JM; Blanes M; Norman F; Martín-Dávila P
    Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():76-85. PubMed ID: 22542039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.